Meta Platforms Inc vs UnitedHealth Group Inc — how do they compare? Meta Platforms Inc trades at $643 (market cap $1.64T), while UnitedHealth Group Inc trades at $421.64 (market cap $386.95B). The key difference: Meta Platforms Inc is far larger — about 4.2× UnitedHealth Group Inc's market cap, and UnitedHealth Group Inc pays the higher dividend (2.18%). Which is the better fit depends on your goals.
| META | UNH | |
|---|---|---|
Market Cap | $1.64T | $386.95B |
Volume | 24,093,972 | — |
Sector | Media | Health |
52-Week High | $790.00 | $431.68 |
52-Week Low | $525.72 | $237.77 |
Enterprise Value | $1.65T | $433.64B |
Dividend Yield | 0.33% | 2.18% |
Signals from Pluang's Aura AI — not financial advice
META trades at $648.37, up 0.37% with strong bullish technical signals and consistent earnings beats. The company shows robust fundamentals with $201B revenue, 32.8% net margin, and positive cash flow trends. Recent AI developments including Muse Spark launch and institutional buying signal growth momentum. Technical indicators show bullish moving averages with support at $631 and resistance at $657.
META presents compelling investment potential with strong analyst support (79% buy rating) and 24% upside to consensus target of $807.17. Key risks include regulatory lawsuits and high capital expenditures, but AI innovation and earnings momentum support long-term growth. The stock offers attractive valuation at 23.5x P/E given projected 2026 revenue growth to $215B.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% today, with strong technical momentum indicated by bullish moving averages and a consensus analyst price target of $466.41. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $6.38 surpassing estimates of $4.94. Revenue reached $447.57 billion in 2025, though net income margin declined to 2.68%. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
UNH presents a favorable outlook supported by analyst optimism (82.7% buy ratings) and structural industry tailwinds like aging demographics. Key risks include regulatory scrutiny, as seen in recent state lawsuits, and margin pressure from rising costs. The stock's valuation at a P/E of 32.09 requires sustained earnings growth to justify further upside, making execution on cost management and growth initiatives critical for investors.
Trailing returns across standard periods
Latest headlines on both assets
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →